Patients with paraplegia are not currently eligible for clinical stem cell transplantation because the effectiveness of stem cell therapy in patients with paraplegia is unclear. 1. Stem cells have not yet been applied to the paraplegic patient population. Stem cell transplantation for the treatment of paraplegia has only been used in animal experiments, and there is a lack of clinical human cases and related research, so the technology cannot be applied to humans at this time. 2. The effectiveness of stem cell transplantation in treating paraplegia is unclear. Although stem cells have various differentiation potentials and can theoretically differentiate into neural stem cells to repair the injured spinal cord and nerve roots, they also have the potential to differentiate into cancer cells, so the efficacy of stem cell therapy for paraplegia is unclear and has not yet been approved for clinical use. It is recommended that paraplegic patients actively receive rehabilitation therapies such as acupuncture and electrical stimulation on a daily basis, and with the advancement of medicine, a cure for paraplegia may emerge in the near future.